Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefani Spranger

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Trends in Cancer|November 11, 2019
Tissue Site and the Cancer Immunity CycleBrendan L Horton, Tim B Fessenden, Stefani Spranger
Cancer Cell|May 10, 2017
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell TherapyStefani Spranger, Daisy Dai, Brendan Horton, et al.
Advances in Immunology|March 1, 2016
Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer ImmunotherapyStefani Spranger, Ayelet Sivan, Leticia Corrales, et al.
Trends in Cell Biology|September 18, 2018
WNT Signaling in Cancer ImmunosurveillanceLorenzo Galluzzi, Stefani Spranger, Elaine Fuchs, et al.
Cell Research|December 17, 2016
Innate immune signaling and regulation in cancer immunotherapyLeticia Corrales, Vyara Matson, Blake Flood, et al.
Advances in Experimental Medicine and Biology|December 25, 2017
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor MicroenvironmentThomas F Gajewski, Leticia Corrales, Jason Williams, et al.
Cancer Immunology Research|November 4, 2017
Intratumoral CD8<sup>+</sup> T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor ImmunityBrendan L Horton, Jason B Williams, Alexandra Cabanov, et al.
Journal of Translational Medicine|October 6, 2010
Three-day dendritic cells for vaccine development: antigen uptake, processing and presentationMaja Bürdek, Stefani Spranger, Susanne Wilde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human CancersJason J Luke, Riyue Bao, Randy F Sweis, et al.
Molecular and Biochemical Parasitology|May 2, 2009
Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibilityShanta M Messerli, Ravi S Kasinathan, William Morgan, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Trends in Cancer|November 11, 2019
Tissue Site and the Cancer Immunity CycleBrendan L Horton, Tim B Fessenden, Stefani Spranger
Cancer Cell|May 10, 2017
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell TherapyStefani Spranger, Daisy Dai, Brendan Horton, et al.
Advances in Immunology|March 1, 2016
Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer ImmunotherapyStefani Spranger, Ayelet Sivan, Leticia Corrales, et al.
Trends in Cell Biology|September 18, 2018
WNT Signaling in Cancer ImmunosurveillanceLorenzo Galluzzi, Stefani Spranger, Elaine Fuchs, et al.
Cell Research|December 17, 2016
Innate immune signaling and regulation in cancer immunotherapyLeticia Corrales, Vyara Matson, Blake Flood, et al.
Advances in Experimental Medicine and Biology|December 25, 2017
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor MicroenvironmentThomas F Gajewski, Leticia Corrales, Jason Williams, et al.
Cancer Immunology Research|November 4, 2017
Intratumoral CD8<sup>+</sup> T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor ImmunityBrendan L Horton, Jason B Williams, Alexandra Cabanov, et al.
Journal of Translational Medicine|October 6, 2010
Three-day dendritic cells for vaccine development: antigen uptake, processing and presentationMaja Bürdek, Stefani Spranger, Susanne Wilde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human CancersJason J Luke, Riyue Bao, Randy F Sweis, et al.
Molecular and Biochemical Parasitology|May 2, 2009
Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibilityShanta M Messerli, Ravi S Kasinathan, William Morgan, et al.
Pageof 9